Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute KaketsukenfiledCriticalChemo Sero Therapeutic Research Institute Kaketsuken
Priority to JP3655578ApriorityCriticalpatent/JPS55304A/ja
Priority to CA312,397Aprioritypatent/CA1108051A/en
Publication of JPS55304ApublicationCriticalpatent/JPS55304A/ja
Publication of JPS6145610B2publicationCriticalpatent/JPS6145610B2/ja
Recombinant dna molecules,process for their production,their use for production of hepatitis b surface antigen(hbsag)and pharmaceutical compositions containing this hbsag
Combinazione di interferone di induttori di interferone con prodotti del tabacco' nuovi componenti e sistema di erogazione per prevenire il cancro,per promuovere il funzionamento in salute dei polmoni e per aumentare la resistenza ai virus ed agli agenti nocivi ambientali